Related Experiment Video
Updated: May 7, 2026
04:50
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
An update on liver surgery for cholangiocarcinoma
Karim Boudjema1, Giovanni Battista Levi Sandri, Eveline Boucher
1Service de Chirurgie Hépatobiliaire et Digestive, Centre Hospitalier Universitaire de Rennes, Université de Rennes 1, Rennes Cedex, France, karim.boudjema@chu-rennes.fr.
Updates in Surgery
|October 3, 2013
Summary
This study reviews methods to improve surgical success for cholangiocarcinoma, a bile duct cancer. It defines limits for treatments to ensure benefits outweigh risks for intra-hepatic and perihilar cholangiocarcinomas.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Cholangiocarcinoma is a malignant neoplasm arising from biliary epithelial cells.
- Complete tumor resection is the primary curative treatment for intra-hepatic and perihilar cholangiocarcinomas (PHCs).
Purpose of the Study:
- To update and discuss methods for increasing the resectability of cholangiocarcinomas.
- To define the limits where treatment risks exceed benefits.
- To analyze intra-hepatic cholangiocarcinomas and PHCs separately regarding origin and resectability.
Main Methods:
- Separate analysis of intra-hepatic cholangiocarcinomas and PHCs.
- Review of surgical techniques and optimization strategies.
- Discussion of the role of liver transplantation in cholangiocarcinoma management.
Main Results:
- Identified factors influencing tumor resectability based on origin.
- Outlined strategies for pre-operative hepatic optimization.
- Evaluated the potential impact of liver transplantation on treatment outcomes.
Conclusions:
- Optimizing surgical approaches can improve cholangiocarcinoma resectability.
- Careful consideration of treatment risks versus benefits is crucial.
- Liver transplantation may play a role in select cholangiocarcinoma cases.